/Wap-Int3-knockout mice also developed mammary tumors at a frequency similar to Rbpj heterozygous and Wap-Int3 control mice but with a slightly longer latency. Thus, the effect on mammary gland development is dependent on the interaction of the Notch ICD with the transcription repressor/activator Rbpj, and Notch-induced mammary tumor development is independent of this interaction.
Introduction
The Notch signaling pathway is an evolutionarily conserved intercellular signaling mechanism (reviewed by Callahan and Egan, 2004) . Genes of the Notch family encode transmembrane receptors that interact with membrane-bound ligands encoded by the Delta/Serrate/Jagged gene families. The signal induced by ligand binding is transmitted by a process involving proteolytic cleavage of the receptor by g-secretase followed by nuclear translocation of the Notch intracellular domain (ICD). The Notch ICD translocates to the nucleus and serves as a transcription activator. The Notch ICD does not possess DNA binding activity; rather it associates with the transcription factor Rbpj, the primary transcriptional mediator of canonical Notch signaling. The Notch-ICD-Rbpj complex transactivates promoters containing Rbpj-binding sites (Kato et al., 1996) .
Evidence for a link between Notch signaling and mammary tumorigenesis came from observations that integration of the mouse mammary tumor virus (MMTV) into the Notch4 gene leads to the formation of mammary tumors (Gallahan and Callahan, 1987) . MMTV integration into Notch4 results in the transcription of a truncated Notch4 mRNA species (designated as Int3) that represents a gain-of-function mutation (Robbins et al., 1992; Kordon et al., 1995; Gallahan and Callahan, 1997; Raafat et al., 2004) . Expression of Int3 under control of mammary-specific regulatory elements in transgenic mice confirmed that activation of Notch signaling leads to the establishment of mammary tumors in 100% of female mice (Jhappan et al., 1992; Gallahan et al., 1996) . Expression of Int3 as a transgene from the whey acidic protein (Wap) promoter or the MMTV-Long terminal repeat (LTR) in transgenic mice blocks normal mammary lobular development and the ability of these females to lactate (Jhappan et al., 1992; Smith et al., 1995; Gallahan et al., 1996) . Wap-and MMTV-Int3 mice develop mammary tumors with 100% penetrance in breeding and nulliparous females (Jhappan et al., 1992; Smith et al., 1995; Gallahan et al., 1996) .
A variant Int3 RNA species was detected in certain human tumor cell lines and was designated as h-Int3sh (Imatani and Callahan, 2000) . Int3sh is missing sequences encoding the Rbpj-binding region (RAM23) of the Notch4 ICD. We have shown that h-Int3sh can still activate transcription from the Hes1 promoter, although at a reduced efficiency (Raafat et al., 2004) . Interestingly, mammary gland development in transgenic mice overexpressing h-Int3sh under the control of Wap promoter (Wap-h-Int3sh) appears normal and the females lactate (Raafat et al., 2004) . However, multiparous Wap-h-Int3sh females develop mammary tumors. These results are compatible with the concept of a gradient in Notch4 signaling affecting mammary gland development and tumorigenesis. In this model, impairment of mammary gland development requires high levels of Notch signaling, whereas induction of mammary tumors by activated Notch4 would require lower levels of Notch signaling. The aim of this study was to investigate, in vivo, the biological role of Int3-Rbpj-dependent and Int3-Rbpj-independent signaling pathways in mammary gland development and tumorigenesis.
Results

Inactivation of Rbpj and mammary gland development
The MMTV LTR-Int3 and Wap-Int3 transgenic mice exhibit two phenotypes with 100% penetrance: lack of mammary alveolar/lobular development and mammary tumor development, respectively (Jhappan et al., 1992; Gallahan et al., 1996) . To determine whether these phenotypes are a consequence of a canonical Int3/Rbpj signaling pathway, we conditionally deleted exons 6 and 7 of the Rbpj gene in the presence of the mammary gland-specific Wap-Cre transgene (Figure 1a ). Exons 6 and 7 encode the DNA-binding and Notch-binding domains, and loss of these exons results in the complete loss of Rbpj-mediated Notch signaling (Han et al., 2002) . In addition, RT-PCR analysis of total RNA extracted from three independent tumors of Rbpj knockout and Rbpj control mice showed that only the Rbpj knockout tumor RNAs are negative for neomycin phoshotransferase (Neo) RNA (Figure 1b) . Through a series of genetic crosses between Wap-Cre, Rbpj flox/flox and WapInt3 mice, female mice with the following genotypes were obtained: The functional unit in the mammary gland during lactation is the alveolus, which produces and secretes milk. In the normal mammary gland, the lobules and their alveoli start to expand at day 5 of pregnancy (Oakes et al., 2006) and continue their growth and differentiation during gestation to form functionally active glandular structures that secrete milk proteins. However, as shown in Figure 2 and earlier (Gallahan et al., 1996) , by day 1 of lactation, expression of WapInt3 in Wap-Int3/Rbpj control mice exhibits an impaired ability to form functionally competent alveolar/lobular structures as observed in whole mounts and histological sections of mammary glands (panels a and e, respectively) as compared with normal lactating wild-type FVB/N mammary glands (panels d and h, respectively). Similarly, alveolar/lobular development in mammary glands from day 1 lactating Wap-Int3/Rbpj heterozygous mice are inhibited to a similar degree, as these females are unable to nurse their pups (Figures 2b and f, respectively). To determine whether the lack of alveolar/ lobular development in the mammary glands of WapInt3/Rbpj heterozygous and Wap-Int3/Rbpj control mice was also reflected in milk composition, b-casein levels were measured by immunohistochemistry (IHC) (Figure 2 ). b-Casein production was high in the FVB/N mammary gland ( Figure 2l ) and not detectable in the mammary glands of Wap-Int3/Rbpj heterozygous (panel j) and Wap-Int3/Rbpj control mice (panel i).
The effects of Wap-Int3 expression on mammary gland development are not manifested in Wap-Int3/Rbpj knockout females. The morphology of the mammary gland (in the whole mount and histology section Figure  2c and g, respectfully) from day1 lactating females is very similar to the normal FVB/N mammary gland, and b-casein can be detected in the alveolar/lobular structures (Figure 2k ). In addition, the Wap-Int3/Rbpj knockout females can successfully nurse their pups. Mammary tumorigenesis is independent of Rbpj function Morphological analysis of mammary glands revealed the presence of focal hyperproliferative lesions arising within the mammary ducts of Wap-Int3/Rbpj knockout, Wap-Int3/Rbpj heterozygous and Wap-Int3/Rbpj control females (Figure 3a) . Irrespective of the genotype, the number of the lesions averaged 24 per gland (Figure 3b ). By the second pregnancy, 80% of the Wap-Int3/Rbpj heterozygous and Wap-Int3/Rbpj control mice developed mammary tumors (Figure 3c ). However, tumor-free survival was longer in the Wap-Int3/Rbpj knockout females: 80% of them developed tumors after three or four pregnancies. Thus, although the loss of Rbpj function seems to have no effect on Int3-induced mammary tumorigenesis, it may affect the rate of tumor cell proliferation.
Histological analysis of the primary mammary tumors showed that they are primarily solid (Figures 3d-f ) or papillary mammary adenocarcinomas (Figures 3g-i Figure 3h (arrows) in a Wap-Int3/Rbpj heterozygous tumor are irregular and consist of hyperchromic cells with areas of more florid proliferation. The stromal axis is not as evident within the papillary formations. Streams of dense connective cells can be identified surrounding the papillary lesion. In the Wap-Int3/Rbpj control tumor shown in Figure 3i , the papillary formations are smaller and less numerous (arrows) and are mixed with microglandular structures. Epithelial tumor cells are more tightly packed and regular in shape and size and the stromal component is less evident. and FVB (d, h and l) mice collected from the number 4 inguinal mammary gland from day 1 lactating mice. Of the experimental mice, only the Wap-Int3/Rbpj knockout mice were able to lactate, showed normal alveolar development (c, g) and were positive for the milk protein, b-casein (k), confirming the morphological and histological observations. Panels a-h are at Â 10 original magnification and panels i-l are at Â 40 original magnification. Each treatment group contained at least 10 mice.
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To confirm the malignant nature of the Wap-Int3/ Rbpj knockout tumors, fragments of nine independent tumors were transplanted bilaterally into the mammary glands of nine female nude mice. These were compared with three independent Wap-Int3/Rbpj control tumors transplanted into six mammary glands in nude mice. Transplantation of both Wap-Int3/Rbpj knockout and control tumors was 100% successful (data not shown). The transplanted Wap-Int3/Rbpj knockout tumors had a latency of 8 weeks, whereas the control tumors were detectable at 5 weeks of transplantation. The effect of Rbpj knockout on anchorage-independent growth in soft agar by HC11 and HC11-Int3 mammary epithelial cells It is possible that Notch ICD may function in two ways as a regulator of transcription. Notch ICD can displace the corepressors from Rbpj and this by itself may be sufficient to indirectly activate the expression of target genes that are independent of a Notch/Rbpj interaction. This has been referred to as a Notch ICD permissive signaling pathway ). Alternatively, the Notch ICD may be required not only to alleviate repression by Rbpj, but also to activate the expression of Notch target genes Bray, 2000, 2001; Bray and Furriols, 2001 ). We therefore have developed HC11 and HC11-Int3 cell lines that were stably infected with Rbpj short hairpin RNA (shRNA) expression vectors. A reverse transcriptase PCR assay of Rbpj RNA expression in these cells is shown in The capability for anchorage-independent growth by tissue culture cells in soft agar is accepted as a measure of their tumor-inducing potential. We have shown previously (Robbins et al., 1992) and in Figure 7d (lane 1) that the HC11 mouse mammary epithelial cells cannot grow in soft agar, whereas HC11-Int3 cells do have this capability (Figure 7d, lane2) . If Notch females results in the formation of basal cell populations and an absence of alveolar structures. Transplantation of mammary tissue from these mice demonstrated that development of the ductal tree was normal, suggesting that Rbpj is not necessary for the establishment of this structure. In contrast, mammary gland development occurs normally in Wap-Cre/Rbpj fl/fl females and they can nurse their pups. Expression from the MMTV LTR begins early during mammary gland development, whereas expression from the Wap promoter peaks around day 15 of pregnancy. This is consistent with there being a window of time during which endogenous Notch/Rbpj signaling is required to promote the development of alveolar/lobular structures. Thus, by the time the Wap promoter is active, endogenous Notch/Rbpj signaling has ceased.
Molecular consequences of
In Wap-Int3 female mammary glands, ductal development is normal but alveolar development does not occur (Gallahan et al., 1996) . We interpret this to mean that target cells affected by WAP-Int3/Rbpj signaling must be alveolar committed progenitor cells downstream of those affected by endogenous Notch/Rbpj signaling. Thus, in the Wap-Cre/Rbpj fl/fl /Wap-Int3 females, loss of Rbpj allows mammary gland development to proceed normally. The effect of Int3/Rbpj signaling on mammary gland development is not unique to Notch4/Int3. Transgenic mice containing either mouse MMTV-LTR-Notch1-ICD or mouse Notch3-ICD have mammary gland phenotypes that are very similar to that observed in MMTV LTR-Int3 mice, namely mammary alveolar/lobular development is suppressed and mammary tumor development occurs (Hu et al., 2006) . How does inappropriate Notch/Rbpj signaling block normal mammary gland development? One possibility is suggested by the work of Leong et al. (2007) , who have shown that the transcriptional E-box binding repressor Slug is a direct target gene in the canonical Notch/Rbpj signaling pathway and that Slug expression leads to epithelial-to-mesenchymal transition by repressing the expression of E-cadherin. Mutations in the E-cadherin gene (CDH1) in breast cancer have been well documented (reviewed in Yoder et al., 2007) . E-cadherin is involved in many cellular processes including morphogenesis, adhesion, recognition, communication and 
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The effect of Rbpj knockout on mammary tumorigenesis
Although deletion of Rbpj in the mammary gland suppresses the negative effect of Int3 signaling on mammary alveolar development, it has little effect on the frequency of hyperproliferative lesions within individual mammary glands (average of 24 per gland), and also on the frequency of Int3-induced mammary tumors. In fact, 100% of the breeding Wap-Int3/Rbpj knockout females develop mammary tumors that could be transplanted in nude mice, although in each case, respectively, with a longer latency than the Wap-Int3/ Rbpj control tumors. The longer latency of primary and secondary tumor development in the Wap-Int3/Rbpj knockout mice could be due to the fact that these glands fully develop and are more differentiated than the Wap-Int3/Rbpj control mammary glands. Similarly, Notch/Rbpj-induced Slug expression in MDA MB 231 tumor cells leads to epithelial-to-mesenchymal transition and confers on them the ability to form tumors in immunodeficient mice (Leong et al., 2007) . Expression of a dominant negative mutant of Rbpj delayed but did not completely block tumor growth of the MDA-MB-231 cells. Therefore, Notch/Rbpj signaling may be involved in the initiation of tumor development by sequestering or interacting with different transcriptional corepressors or activators or by regulating the expression of a different subset of target genes. Immunohistochemical analysis of the primary and transplanted Rbpj knockout tumors for Neo, wild-type RBP-J and the targets of Notch signaling, Hes1 and Hey2, demonstrated that these tumors were negative for each of these proteins. This suggests that a minimum level of Int3/Rbpj signaling is not required for the sustained growth of the primary or transplanted mammary tumors. However, our results cannot exclude the possibility that during the first pregnancy of the Wap-Int3/Rbpj knockout mice, there is a heterogeneity of cells in the mammary gland expressing WapCre and WAP-Int3, and that in those cells not expressing Wap-Cre, as noted above, Int3/Rbpj signaling could be involved in the initiation of mammary tumorigenesis.
We have also examined the requirement for Rbpj expression on the ability of HC11 and HC11-Int3 mammary epithelial cells to grow in soft agar. It is possible that the function of Int3 is simply to derepress RBP-J repressed genes and does not affect the activation of their transcription as suggested by Furriols and Bray (2001) . Although the expression of several genes was derepressed in HC11 cells that were stably infected with vectors expressing Rbpj shRNA (unpublished data), the expression of these cellular genes did not confer on HC11 cells the capability to grow in soft agar. Furthermore, the stable expression of Rbpj shRNA in HC11-Int3 cells did not affect their ability to grow in soft agar. In a related study, Stylianou et al. (2006) presented evidence that constitutively activated Rbpj-VP16 confers on normal human mammary MCF10A epithelial cells the ability to grow in soft agar, resistance to the induction of apoptosis and a reduction in E-cadherin expression. This is in contrast to our findings in which knockdown of Rbpj expression in HC11-Int3 cells did not negatively affect their ability to grow in soft agar. In addition, the level of apoptosis in the Rbpj knockout tumors was significantly lower than in the Rbpj control tumors. There are several aspects of these experiments that are difficult to evaluate. For instance, it is not known whether the chimeric activated Rbpj-VP16 protein possesses other novel properties that are not inherent to those exhibited by a wild-type Notch ICD/Rbpj interaction. It is also possible that the mechanism by which Notch1 ICD and Int3 induce mammary tumorigenesis is different, as the Notch1 ICD has a trans-activating domain C 0 terminal to the ankyrin repeats that is missing in Int3.
Taken together, our data is most consistent with the concept that constitutive Int3 signaling blocks mammary alveolar development through an Rbpj-dependent pathway and that Int3-induced mammary tumorigenesis or mammary tumor growth occurs as a consequence of Int3 signaling that is not dependent on a canonical Rbpjdependent pathway. Earlier reports have suggested that there are components of Notch signaling that occur independently of Rbpj and, in the case of Notch1, may be involved in neoplastic transformation (Shawber et al., 1996; Dumont et al., 2000; Jeffries and Capobianco, 2000; Levy et al., 2002; MacKenzie et al., 2004) . In the literature, at least three additional binding partners for the Notch ICD have been reported: Deltex (Dtx) (luo et al., 2005) , Hypoxia-induced factor-1a (Hif1a) (Zheng et al., 2008) and nuclear factor of k light polypeptide gene enhancer in B-cells (Shin et al., 2006) . Whether any one of these candidate binding partners or some as yet unknown binding partner collaborates with the Notch4 ICD to contribute to mammary tumorigenesis will be the subject of future studies.
Materials and methods
Mouse breeding and genotyping
We employed a mouse strain carrying a LoxP-flanked (floxed) Rbpj gene (Rbpj flox/flox ) provided by Dr Tasuku Honjo (Kyoto University, Kyoto, Japan), which has been described elsewhere (Han et al., 2002; Buono et al., 2006) Screening tail DNA for inheritance of the floxed Rbpj and Wap-Int3 genes was performed by PCR as reported previously (Buono et al., 2006; Gallahan et al., 1996) . Wap-Cre transgene was determined by PCR using the following primers: forward, 5 0 -CATCACTCGTTGCATCGACCGG-3 0 ; and reverse, 5 0 -TA GAGCTGTGCCAGCCT CTTC-3 0 . DNAs were amplified for 34 cycles (94 1C for 30 s, 56 1C for 45 s and 72 1C for 1 min).
Preparation of mammary tissue for analysis and transplantation
Mice were euthanized and mammary glands were examined grossly under a dissecting microscope. Mammary whole mounts and histology sections were prepared from the fourth abdominal gland as described previously (Raafat et al., 2004) . Tumor tissue transplants were prepared as described previously (Raafat et al., 2007) ; briefly viable tissue from Rbpj control and knockout mammary tumors was transplanted into the inguinal mammary glands of 10-week-old recipients (homozygous athymic NCR-nu females). All the recipients were kept as nulliparous mice and were palpated twice weekly. Experiments were repeated at least twice, and at least five mice were used in each experiment.
Immunohistochemistry
Immunohistochemical analysis was carried out as described previously (Raafat et al., 2007) . Primary antibodies were diluted: 500 Â ; b-casein (SC-30042), 200X; Hes-1 (SC-25392), 200X; Hey-2 (Protein Tech Group, Inc-10597-1-AP), 200X; Neo (USBiological-N2008-05), 500X; and Rbpj (SC-8213), 500 Â , PCNA (sc-9857), 100 Â , in phosphate-buffered saline-1% bovine serum albumin. Appropriate biotinylated secondary anti-goat (PK-6105, Vector Laboratories Inc., Burlingame, CA, USA) or anti-rabbit (PK-6101, Vector Laboratories Inc., Burlingame, CA, USA) antibodies were diluted according to the manufacturer's recommendations. For apoptosis, the Roche in situ cell detection POD kit (1684817, Roche, Indianapolis, IN, USA) was used according to the manufacturer's recommendations. Labeling index was determined in at least a total of 3000 cells in each experimental condition.
Lentivirus production and transduction, proliferation and colony growth in soft agar HEK293T/17 cells were purchased from the ATCC (Mannassas, VA, USA) and grown in DMEM, supplemented with 10% fetal bovine serum and Pen/Strep (Invitrogen; Carlsbad, CA, USA). A shRNA knockdown vector for murine Rbpj, derived from the RNAi consortium, was purchased from Open Biosystems Inc. (Huntsville, AL, USA). Purchased Clone ID numbers included TRCN0000097284-88 and were designated as H2 through H6, respectively. A control vector expressing the nontarget shRNA sequence (CCGGCAACAAGATGAA GAGCACCAACTCGAGTTGGTGCTCTTCATCTTGTTG TTTTT) was purchased from Sigma-Aldrich (St Louis, MO, USA). The lentiviral helper plasmids, psPax2 and pMD2.G, were purchased from Addgene (Cambridge, MA, USA). All viral work conformed to accepted Biosafety Level 2 þ guidelines as described by the National Institutes of Health (http://bmbl.od.nih.gov/contents.htm). Briefly, knockdown vectors (H2-H6) were cotransfected with helper plasmids (psPax2 and pMD2.G) in a ratio of 10:7.5:3, respectively, in HEK293T/17, using FugeneHD (Roche Applied Science; Indianapolis, IN, USA). HC11 mouse mammary epithelial cells were transduced with lentiviral particles at approximately 40% confluence for 8-12 h followed by replacement with fresh media. Cells were selected for puromycin (4.5 mg/ml, SigmaAldrich, St Louis, MO, USA) resistance 36 h post-infection. For proliferation, cells were plated at a density of 1 Â 10 3 per well in 24-well plates in regular growing media (day 0). The number of cells was determined every day until confluence using a Coulter counter.
The proliferation ratios were calculated from the initial start point (day 0) and the data presented are the mean of three independent experiments. Soft agar colony growth was conducted as described previously (Raafat et al., 2007) . Colonies measuring 0.2 mm or larger were counted using the AccuCount 1000 colony counter (Biologics Inc., Manassas, VA, USA).
Statistics
Quantitative values are represented as the mean of at least three experiments. All in vivo experiments were repeated at least three times, and at least five mice were used in each experiment. The statistical significance of the difference between groups was determined by the Wilcoxon rank sum test. Comparisons resulting in P-values less than 0.05 were considered as statistically significant and identified in the figures with an asterisk (*).
